Modulation of age at onset in Huntington's disease and spinocerebellar ataxia type 2 patients originated from eastern India

Neuroscience Letters

Volumn 345, Issue 2, 2003, Pages 93-96

  Chattopadhyay, Biswanath ^a   Ghosh, Subho ^a   Gangopadhyay, Prasanta K ^b   Das, Shaymal K ^b   Roy, T ^b   Sinha, Krishna K ^c   Jha, Dilip K ^c   Mukherjee, Subhash C ^d   Chakraborty, Ambar ^e   Singhal, Bhim S ^f   Bhattacharya, Anup K ^g   Bhattacharyya, Nitai P ^a  

^a SAHA INSTITUTE OF NUCLEAR PHYSICS   (India)

^b BANGUR INSTITUTE OF NEUROLOGY   (India)

^c Advanced Diagnostic Centre   (India)

^d MEDICAL COLLEGE AND HOSPITAL   (India)

^e VIVEKANANDA INSTITUTE OF MEDICAL SCIENCES   (India)

^f BOMBAY HOSPITAL   (India)

^g Student's Health Home   (India)

Author keywords

CA150 locus; GluR6 locus; Huntington's disease; Modifiers; RAI1 locus; SCA2

Indexed keywords

HUNTINGTIN;

ALLELE; ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; GENE LOCUS; GENOTYPE; HUMAN; HUNTINGTON CHOREA; INDIA; MAJOR CLINICAL STUDY; MULTIPLE REGRESSION; ONSET AGE; PRIORITY JOURNAL; SPINOCEREBELLAR DEGENERATION;

EID: 0038042172     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(03)00436-1     Document Type: Article

References (12)

1. Basu P., Chattopadhyay B., Gangopadhyay P.K., Mukherjee S.C., Sinha K.K., Das S.K., Roychoudhury S.C., Majumder P.P., Bhattacharyya N.P. Analysis of CAG repeats in SCA1, SCA2, SCA3, SCA6, SCA7 and DRPLA loci in spinocerebellar ataxia patients and distribution of CAG repeats at the SCA1, SCA2 and SCA6 loci in nine populations of eastern India. Hum. Genet. 106:2000;597-604.
2. Hayes S., Turecki G., Brisebois K., Lopes-Cendes I., Gaspar C., Riess O., Ranum L.P.W., Pulst M.S., Rouleau G.A. CAG repeat length in RAI1 is associated with age at onset variability in spinocerebellar ataxia type 2 (SCA2). Hum. Mol. Genet. 9:2000;1753-1758.
3. Holbert S., Denghien I., Kiechle T., Rosenblatt A., Wellington C., Hayden M.R., Margolis R.L., Ross C.A., Dausset J., Ferrante R.J., Neri C. The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: neuropathologic and genetic evidence for a role in Huntington's disease. Proc. Natl. Acad. Sci. USA. 98:2001;1811-1816.
4. Koshy B.T., Zoghbi H.Y. The CAG/polyglutamine tract diseases: gene products and molecular pathogenesis. Brain Pathol. 7:1997;927-942.
5. MacDonald M.E., Vonsattel J.P., Srinidhi J., Couropmitree N.N., Cupples L.A., Bird E.D., Gusella J.F., Myers R.H. Evidence for the GluR6 gene associated with younger onset age of Huntington's disease. Neurology. 53:1999;1330-1332.
6. Naze P., Vuillaume I., Destee A., Pasquier F., Sablonniere B. Mutation analysis and association studies of the ubiquitin carboxy-terminal hydrolase L1 gene in Huntington's disease. Neurosci. Lett. 328:2002;1-4.
7. Pramanik S., Basu P., Gangopadhaya P.K., Sinha K.K., Jha D.K., Sinha S., Maity B.K., Mukherjee S.C., Roychoudhury S.C., Majumder P.P., Bhattacharyya N.P. Analysis of CAG and CCG repeats in Huntingtin gene among HD patients and normal populations of India. Eur. J. Hum. Genet. 8:2000;678-682.
8. Rubinsztein D.C., Leggo J., Chiano M., Dodge A., Norbury G., Rosser E., Craufurd D. Genotypes at the GluR6 kainate receptor locus are associated with variation in the age of onset of Huntington's disease. Proc. Natl. Acad. Sci. USA. 94:1997;3872-3876.
9. Sanpei K., Takano H., Igarashi S., Sato T., Oyake M., Sasaki H., Wakisaka A., Tashiro K., Ishida Y., Ikeuchi T., Koide R., Saito M., Tanaka T., Hanyu S., Takiyama Y., Nishizawa M., Shimizu N., Nomura Y., Segawa M., Iwabuchi K., Eguchi I., Tanaka H., Takahashi H., Tsuji S. Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT. Nat. Genet. 14:1996;277-284.
10. Squitieri F., Andrew S.E., Goldberg Y.P., Kremer B., Spence N., Zeisler J., Nichol K., Theilmann J., Greenberg J., Goto J., Kanazawa I., Vesa J., Peltonen L., Almqvist E., Anvret M., Telenius H., Lin B., Napolitano G., Morgan K., Hayden M.R. DNA haplotype analysis of Huntington disease reveals clues to the origins and mechanisms of CAG expansion and reasons for geographic variations of prevalence. Hum. Mol. Genet. 3:1994;2103-2114.
11. Squitieri F., Cannella M., Giallonardo P., Maglione V., Mariotti C., Hayden M.R. Onset and pre-onset studies to define the Huntington's disease natural history. Brain Res. Bull. 56:2001;233-238.
12. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosome. Cell. 72:1993;971-983.